Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor

Radiology

Volumn 265, Issue 1, 2012, Pages 175-185

  Gorelik, Michael ^a   Orukari, Inema ^a   Wang, Joanne ^a   Galpoththawela, Shashikala ^a   Kim, Heechul ^a   Levy, Michael ^a   Gilad, Assaf A ^a   Bar Shir, Amnon ^a   Kerr, Douglas A ^a,b   Levchenko, Andre ^a   Bulte, Jeff W M ^a   Walczak, Piotr ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MOLDAY ION; RHODAMINE; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CAROTID ARTERY; CELL ADHESION; CELL HOMING; CELL TRACKING; CONTROLLED STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; FEMALE; GENE DELIVERY SYSTEM; GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MICROFLUIDICS; MOLECULAR DOCKING; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SIGNAL DETECTION; TARGET CELL;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CAROTID ARTERIES; CELL ADHESION; CELL TRACKING; CONTRAST MEDIA; DEXTRANS; GENE EXPRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTEGRIN ALPHA4BETA1; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICROFLUIDICS; MICROSCOPY, FLUORESCENCE; NEUROGLIA; RATS; RECEPTORS, VERY LATE ANTIGEN; RHODAMINES; TRANSFECTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84866611382     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112212     Document Type: Article

References (36)

1. Berman SC, Galpoththawela C, Gilad AA, Bulte JW, Walczak P. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med 2011;65(2):564-574.
2. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010;6(7):363-372.
3. Winkler C, Kirik D, Björklund A. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 2005;28(2):86-92. (Pubitemid 40178925)
4. Janowski M, Walczak P, Date I. Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results. Stem Cells Dev 2010;19(1):5-16.
5. Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112(10):1451-1461. (Pubitemid 41291771)
6. Li L, Jiang Q, Ding G, et al. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia: an MRI study. J Cereb Blood Flow Metab 2010;30(3):653-662.
7. Shen LH, Li Y, Chen J, et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006;137(2):393-399. (Pubitemid 43031506)
8. Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 2001;49(5):1196-1203; discussion 1203-1204.
9. Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008;39(5):1569-1574.
10. Pendharkar AV, Chua JY, Andres RH, et al. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 2010;41(9):2064-2070.
11. Guzman R, De Los Angeles A, Cheshier S, et al. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 2008;39(4):1300-1306. (Pubitemid 351440705)
12. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 2006;113(4):477-485.
13. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4 β1 integrin. Nature 1992;356(6364):63-66.
14. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67(10):1187-1194.
15. Barnett BP, Arepally A, Karmarkar PV, et al. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med 2007;13(8):986-991. (Pubitemid 47222036)
16. Karmarkar PV, Kraitchman DL, Izbudak I, et al. MR-trackable intramyocardial injection catheter. Magn Reson Med 2004;51(6):1163-1172. (Pubitemid 38797001)
17. Rey S, Lee K, Wang CJ, et al. Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia. Proc Natl Acad Sci U S A 2009;106(48):20399-20404.
18. Walczak P, All AH, Rumpal N, et al. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia 2011;59(3):499-510.
19. Correia AS, Anisimov SV, Li JY, Brundin P. Stem cell-based therapy for Parkinson's disease. Ann Med 2005;37(7):487-498. (Pubitemid 41693579)
20. Capetian P, Knoth R, Maciaczyk J, et al. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009;160(3):661-675.
21. Mazzini L, Mareschi K, Ferrero I, et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 2006;28(5):523-526. (Pubitemid 44141321)
22. Kelly S, Bliss TM, Shah AK, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 2004;101(32):11839-11844. (Pubitemid 39095381)
23. Calabrese M, Battaglini M, Giorgio A, et al. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology 2010;75(14):1234-1240.
24. Boncoraglio GB, Bersano A, Candelise L, Reynolds BA, Parati EA. Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev 2010 (9):CD007231.
25. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002;59(4):514-523. (Pubitemid 34919983)
26. Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 2009;18(5):683-692.
27. Semon JA, Nagy LH, Llamas CB, Tucker HA, Lee RH, Prockop DJ. Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels. Cell Tissue Res 2010;341(1): 147-158.
28. Prowse AB, Chong F, Gray PP, Munro TP. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res (Amst) 2011;6(1):1-12.
29. Subileau EA, Rezaie P, Davies HA, et al. Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis. J Neuropathol Exp Neurol 2009;68(3):227-240.
30. Blann A, Kumar P, Krupinski J, McCollum C, Beevers DG, Lip GYH. Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. Blood Coagul Fibrinolysis 1999;10(5):277-284. (Pubitemid 29382668)
31. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10(8):858-864. (Pubitemid 39070860)
32. Janowski M. Functional diversity of SDF-1 splicing variants. Cell Adhes Migr 2009;3(3):243-249.
33. Belmadani A, Tran PB, Ren D, Miller RJ. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 2006;26(12):3182-3191.
34. Chua JY, Guzman R. Intraarterial neural stem cell delivery does not result in reduction of CBF and micro strokes. Stroke 2010;41(4):E354.
35. McCormick PW, Stewart M, Goetting MG, Balakrishnan G. Regional cerebrovascular oxygen saturation measured by optical spectroscopy in humans. Stroke 1991;22(5):596-602.
36. Lu H, Donahue MJ, van Zijl PC. Detrimental effects of BOLD signal in arterial spin labeling fMRI at high field strength. Magn Reson Med 2006;56(3):546-552. (Pubitemid 44338873)